COSCIENS Biopharma Inc. (LON:0UGB)

Market Cap	7.80M
Revenue (ttm)	6.99M
Net Income (ttm)	-13.59M
Shares Out	n/a
EPS (ttm)	-4.68
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1
Average Volume	209
Open	4.200
Previous Close	4.250
Day's Range	4.200 - 4.200
52-Week Range	3.900 - 10.050
Beta	n/a
RSI	42.16
Earnings Date	Aug 8, 2025

About COSCIENS Biopharma

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, Colombia, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a chewable for cholesterol reduction; beta glucan from yeast, a nutraceutical-capsule used as an immune booster; and avenanthramides, a nutraceutical-chewable formulation used to reduce...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1990
• Employees: 40
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0UGB

Financial Performance

In 2024, COSCIENS Biopharma's revenue was $9.59 million, an increase of 34.22% compared to the previous year's $7.14 million. Losses were -$15.31 million, 339.3% more than in 2023.

Financial numbers in USD